Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Barbara Galikowska‐Bogut"'
Autor:
Grzegorz Gołuński, Kinga Konkel, Barbara Galikowska-Bogut, Patrycja Bełdzińska, Katarzyna Bury, Marcin Zakrzewski, Kamila Butowska, Rafał Sądej, Jacek Piosik
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Breast cancer is one of cancer’s most deadly varieties. Its variability makes the development of personalized therapies very difficult. Therefore, improvement of classic chemotherapy is still one of the important challenges of cancer resea
Externí odkaz:
https://doaj.org/article/3f050aa6158e45989c82017dbcb08318
Autor:
Paweł Kamil Serafin, Marta Popęda, Kamila Bulak, Agata Zwara, Barbara Galikowska-Bogut, Anna Przychodzka, Adriana Mika, Tomasz Śledziński, Marcin Stanisławowski, Kamila Jendernalik, Marika Bolcewicz, Wiktoria Laprus, Grzegorz Stasiłojć, Rafał Sądej, Anna Żaczek, Leszek Kalinowski, Patrycja Koszałka
Publikováno v:
Molecular Metabolism, Vol 89, Iss , Pp 102035- (2024)
Objective: CD73 (ecto-5′-nucleotidase, NT5E), a cell-surface enzyme converting 5′-AMP to adenosine, is crucial for cancer progression. However, its role in the tumorigenesis process remains mostly obscure. We aimed to demonstrate CD73's role in b
Externí odkaz:
https://doaj.org/article/b3615b3f61fb402c840c23ea50ec3ddf
Autor:
Grzegorz Gołuński, Kinga Konkel, Barbara Galikowska‑Bogut, Patrycja Bełdzińska, Katarzyna Bury, Marcin Zakrzewski, Kamila Butowska, Rafał Sądej, Jacek Piosik
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/ba3d4376fba44855ab68a104e76d19cf
Autor:
Kamil Mieczkowski, Kamila Kitowska, Marcin Braun, Barbara Galikowska‐Bogut, Monika Gorska‐Arcisz, Dominika Piasecka, Konrad Stawiski, Anna J. Zaczek, Dariusz Nejc, Radzisław Kordek, Hanna M. Romanska, Rafal Sadej
Publikováno v:
Molecular Oncology, Vol 16, Iss 15, Pp 2823-2842 (2022)
We have recently demonstrated that fibroblast growth factor receptor 2 (FGFR2)‐mediated signalling alters progesterone receptor (PR) activity and response of oestrogen receptor α (ER)‐positive (ER+) breast cancer (BCa) cell lines to anti‐ER ag
Externí odkaz:
https://doaj.org/article/dbc206886c77407899872ff4d501edb9
Autor:
Kamil Mieczkowski, Kamila Kitowska, Marcin Braun, Barbara Galikowska‐Bogut, Monika Gorska‐Arcisz, Dominika Piasecka, Konrad Stawiski, Anna J. Zaczek, Dariusz Nejc, Radzisław Kordek, Hanna M. Romanska, Rafal Sadej
Publikováno v:
Molecular Oncology. 16:2823-2842
We have recently demonstrated that fibroblast growth factor receptor 2 (FGFR2)-mediated signalling alters progesterone receptor (PR) activity and response of oestrogen receptor α (ER)-positive (ER+) breast cancer (BCa) cell lines to anti-ER agents.